MEDVi
Featured PartnerDirect-to-consumer telehealth platform selling compounded GLP-1 weight-loss medications and a compounded sublingual ED product, with LegitScript certification.
What we like
What to watch
Full Review
MEDVi has carved out a strong position in the compounded GLP-1 market by combining competitive introductory pricing (179/mo semaglutide) with a no-contract model and LegitScript certification. The partnership with Belmar Pharma Solutions — an FDA-registered compounding pharmacy with 40+ years of operation — provides meaningful supply-chain credibility. The companys expansion into mens ED via the QUAD sublingual product demonstrates ambitions beyond weight loss. Multiple medication formats (injectable and oral for both semaglutide and tirzepatide) give patients flexibility that many competitors lack.
Last researched: 2026-03-30
Pricing
| Treatment | Category | Price/mo | Includes | Notes |
|---|---|---|---|---|
| Compounded Semaglutide (Injectable) | Weight Loss / GLP-1 | $179–$299 | ● Consults○ Lab work● Shipping | $179 first month No subscription needed |
| Compounded Semaglutide (Oral) | Weight Loss / GLP-1 | $249–$369 | ● Consults○ Lab work● Shipping | $249 first month No subscription needed |
| Compounded Tirzepatide (Injectable) | Weight Loss / GLP-1 | $279–$499 | ● Consults○ Lab work● Shipping | $279 first month No subscription needed |
| MEDVi QUAD (4-in-1 ED Sublingual) | Weight Loss / GLP-1 | $119–$199 | ● Consults○ Lab work● Shipping | No subscription needed |